Irish case report links semaglutide to ischaemic optic neuropathy in woman in her 70s
Vision partially improved after semaglutide was stopped in a patient with vascular risk factors who had taken the drug for six months.
MH
By Maren Holt · Senior Reporter, GLP-1
Sep 27 20:00 ETSource: Irish medical journal
The wire
- 01A woman in her 70s with vascular risk factors presented with three days of progressive left-sided visual disturbance, a relative afferent pupillary defect and superior optic disc swelling consistent with NAION after six months on semaglutide.
- 02The report adds to pharmacovigilance signals around semaglutide and eye symptoms, relevant when clinicians assess acute painless monocular visual loss in patients on GLP-1 therapy.
- 03The authors state causality remains unproven; this is a single case with unremarkable haematology and neuroimaging and only partial visual recovery after cessation.
From the source
Read at pubmed.ncbi.nlm.nih.govNon-Arteritic Anterior Ischaemic Optic Neuropathy Associated with Semaglutide use
Irish medical journal · 2026 Sep 28 · Kearney M, Smyth NM, Hassan HSA et al.
Source URL https://pubmed.ncbi.nlm.nih.gov/42808150/
